GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | 8/7/2026 7:14:08 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $23,776,090 | EPS -$0.34 | ||
| KIORA PHARMACEUTICALS INC (KPRX) | 8/7/2026 7:04:09 AM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $23,776,090 | EPS -$0.34 | Export Earnings Model | ||
| KIORA PHARMACEUTICALS INC (KPRX) | 5/8/2026 7:13:46 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $21,227,089 | EPS -$0.58 | ||
| KIORA PHARMACEUTICALS INC (KPRX) | 5/8/2026 7:09:00 AM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $21,227,089 | EPS -$0.58 | Export Earnings Model | ||
| KIORA PHARMACEUTICALS INC (KPRX) | 4/30/2026 6:41:11 PM | View | Proxy | SEC | Y 2025 | ||||||
| KIORA PHARMACEUTICALS INC (KPRX) | 3/25/2026 7:14:43 AM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $24,253,300 | EPS -$2.64 | ||
| KIORA PHARMACEUTICALS INC (KPRX) | 3/25/2026 7:04:18 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $0 | Assets $24,253,300 | EPS -$1.60 | Export Earnings Model | |
| KIORA PHARMACEUTICALS INC (KPRX) | 11/7/2025 6:12:45 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $29,863,454 | EPS $0.01 | ||
| KIORA PHARMACEUTICALS INC (KPRX) | 11/7/2025 6:06:18 AM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $0 | Assets $29,863,454 | EPS $0.01 | Export Earnings Model | |
| KIORA PHARMACEUTICALS INC (KPRX) | 8/8/2025 7:15:38 AM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $0 | Assets $31,945,683 | EPS -$0.54 | Export Earnings Model | |
| KIORA PHARMACEUTICALS INC (KPRX) | 8/8/2025 7:13:59 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $31,945,683 | EPS -$0.54 | ||
| KIORA PHARMACEUTICALS INC (KPRX) | 5/9/2025 7:12:31 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $34,019,862 | EPS -$0.52 | ||
| KIORA PHARMACEUTICALS INC (KPRX) | 5/9/2025 7:02:42 AM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $0 | Assets $34,019,862 | EPS -$0.52 | Export Earnings Model | |
| KIORA PHARMACEUTICALS INC (KPRX) | 4/30/2025 10:01:28 AM | View | Proxy | SEC | Y 2024 | ||||||
| KIORA PHARMACEUTICALS INC (KPRX) | 3/25/2025 7:05:53 AM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $16,020,000 | Assets $36,484,484 | EPS $0.87 | |
| KIORA PHARMACEUTICALS INC (KPRX) | 3/25/2025 7:01:28 AM | View | Financials | Earnings | SEC | Y 2024 | Rev $0 | Assets $36,484,484 | EPS -$1.04 | Export Earnings Model | |
| KIORA PHARMACEUTICALS INC (KPRX) | 11/8/2024 7:12:15 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $38,509,354 | EPS -$0.81 | ||
| KIORA PHARMACEUTICALS INC (KPRX) | 11/8/2024 7:03:10 AM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $0 | Assets $38,509,354 | EPS -$0.81 | Export Earnings Model | |
| KIORA PHARMACEUTICALS INC (KPRX) | 8/9/2024 7:15:41 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $20,000 -55.6% | Assets $40,814,265 | EPS -$0.53 | |
| KIORA PHARMACEUTICALS INC (KPRX) | 8/9/2024 7:02:56 AM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $20,000 -55.6% | Assets $40,814,265 | EPS -$0.53 | Export Earnings Model | |
| KIORA PHARMACEUTICALS INC (KPRX) | 5/10/2024 7:14:40 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $16,000,000 +47,711.1% | Assets $42,440,007 | EPS $0.38 | |
| KIORA PHARMACEUTICALS INC (KPRX) | 5/10/2024 7:03:18 AM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $16,000,000 +47,711.1% | Assets $42,440,007 | EPS $0.38 | Export Earnings Model | |
| KIORA PHARMACEUTICALS INC (KPRX) | 3/25/2024 4:34:04 PM | View | Proxy | SEC | Y 2023 | ||||||
| KIORA PHARMACEUTICALS INC (KPRX) | 3/25/2024 7:19:13 AM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $13,711,870 | EPS -$2.69 | ||
| KIORA PHARMACEUTICALS INC (KPRX) | 3/25/2024 7:04:18 AM | View | Financials | Earnings | SEC | Y 2023 | Assets $13,711,870 | EPS $0.04 | Export Earnings Model | ||
| KIORA PHARMACEUTICALS INC (KPRX) | 11/9/2023 7:18:04 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $49,912 +534.9% | Assets $15,896,443 | EPS -$0.89 | |
| KIORA PHARMACEUTICALS INC (KPRX) | 11/9/2023 7:03:12 AM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $49,912 +534.9% | Assets $15,896,443 | EPS -$0.89 | Export Earnings Model | |
| KIORA PHARMACEUTICALS INC (KPRX) | 8/8/2023 7:27:38 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $45,087 | Assets $19,884,943 | EPS -$0.79 | |
| KIORA PHARMACEUTICALS INC (KPRX) | 8/8/2023 7:15:09 AM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $45,087 | Assets $19,884,943 | EPS -$0.79 | Export Earnings Model | |
| KIORA PHARMACEUTICALS INC (KPRX) | 7/21/2023 4:51:33 PM | View | Proxy | SEC | Y 2022 | ||||||
| KIORA PHARMACEUTICALS INC (KPRX) | 5/9/2023 7:09:45 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $33,465 | Assets $16,527,600 | EPS -$1.00 | |
| KIORA PHARMACEUTICALS INC (KPRX) | 5/9/2023 7:04:39 AM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $33,465 | Assets $16,527,600 | EPS -$1.00 | Export Earnings Model | |
| KIORA PHARMACEUTICALS INC (KPRX) | 4/28/2023 2:20:55 PM | View | Proxy | SEC | Y 2022 | ||||||
| KIORA PHARMACEUTICALS INC (KPRX) | 3/23/2023 7:19:37 AM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $18,678,259 | EPS -$18.55 | ||
| KIORA PHARMACEUTICALS INC (KPRX) | 3/23/2023 7:04:29 AM | View | Financials | Earnings | SEC | Y 2022 | Assets $18,678,259 | EPS $3.51 | Export Earnings Model | ||
| KIORA PHARMACEUTICALS INC (KPRX) | 11/9/2022 6:20:26 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $7,861 +2,935.1% | Assets $17,662,318 | EPS -$6.03 | |
| KIORA PHARMACEUTICALS INC (KPRX) | 8/15/2022 5:57:26 PM | View | Proxy | SEC | Y 2021 | ||||||
| KIORA PHARMACEUTICALS INC (KPRX) | 8/12/2022 6:28:44 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $15,462,863 | EPS -$0.18 | ||
| KIORA PHARMACEUTICALS INC (KPRX) | 8/8/2022 4:32:11 PM | View | Proxy | SEC | Y 2021 | ||||||
| KIORA PHARMACEUTICALS INC (KPRX) | 7/8/2022 5:18:17 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $17,636,276 | EPS -$0.27 | ||
| KIORA PHARMACEUTICALS INC (KPRX) | 7/7/2022 6:18:53 AM | Micro | View | Financials | 10-K/A | SEC | Y 2021 ending: 12/31/2021 | Assets $20,130,308 | EPS -$57.12 | ||
| KIORA PHARMACEUTICALS INC (KPRX) | 4/15/2022 9:18:14 AM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $20,130,308 | EPS -$57.12 | ||
| KIORA PHARMACEUTICALS INC (KPRX) | 11/15/2021 7:45:04 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $259 | Assets $25,493,339 | EPS -$11.34 | |
| EYEGATE PHARMACEUTICALS INC (KPRX) | 8/12/2021 4:34:29 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $18,100,060 | EPS -$0.34 | ||
| Eyegate Pharmaceuticals Inc (KPRX) | 8/12/2021 4:17:40 PM | View | Financials | Earnings | WIRE | 2Q 2021 | Assets $18,100,060 | EPS -$0.34 | Export Earnings Model | ||
| EYEGATE PHARMACEUTICALS INC (KPRX) | 5/12/2021 4:23:52 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $20,620,602 | EPS -$0.27 | ||
| Eyegate Pharmaceuticals Inc (KPRX) | 5/12/2021 4:15:57 PM | View | Financials | Earnings | WIRE | 1Q 2021 | Assets $20,620,602 | EPS -$0.27 | Export Earnings Model | ||
| EYEGATE PHARMACEUTICALS INC (KPRX) | 4/30/2021 4:08:42 PM | View | Proxy | SEC | Y 2020 | ||||||
| EYEGATE PHARMACEUTICALS INC (KPRX) | 3/25/2021 7:11:49 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $12,059 -99.6% | Assets $15,304,164 | EPS -$1.49 | |
| Eyegate Pharmaceuticals Inc (KPRX) | 3/25/2021 4:16:06 PM | View | Financials | Earnings | WIRE | Y 2020 | Rev $12,059 | Assets $15,304,164 | EPS -$0.24 | Export Earnings Model | |
| EYEGATE PHARMACEUTICALS INC (KPRX) | 11/9/2020 4:26:56 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $9,245,100 | EPS -$0.44 | ||
| EYEGATE PHARMACEUTICALS INC (KPRX) | 8/6/2020 4:31:43 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $10,966,902 | EPS -$0.38 | ||
| EYEGATE PHARMACEUTICALS INC (KPRX) | 5/6/2020 4:25:22 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $12,187,214 | EPS -$0.43 | ||
| EYEGATE PHARMACEUTICALS INC (KPRX) | 4/29/2020 4:50:32 PM | View | Proxy | SEC | Y 2019 | ||||||
| EYEGATE PHARMACEUTICALS INC (KPRX) | 3/4/2020 4:27:09 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $2,686,000 +62.5% | Assets $10,112,514 | EPS -$2.23 | |
| EYEGATE PHARMACEUTICALS INC (KPRX) | 11/7/2019 9:06:37 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $8,867,615 | EPS -$1.15 | ||
| EYEGATE PHARMACEUTICALS INC (KPRX) | 8/8/2019 8:48:40 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $10,895,542 | EPS -$0.63 | ||
| EYEGATE PHARMACEUTICALS INC (KPRX) | 5/8/2019 4:32:20 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $2,686,000 +145.1% | Assets $12,439,396 | EPS $0.19 | |
| EYEGATE PHARMACEUTICALS INC (KPRX) | 4/30/2019 4:15:09 PM | View | Proxy | SEC | Y 2018 | ||||||
| EYEGATE PHARMACEUTICALS INC (KPRX) | 3/1/2019 4:27:52 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $1,652,520 +305.5% | Assets $14,280,617 | EPS -$4.57 | |
| EYEGATE PHARMACEUTICALS INC (KPRX) | 11/13/2018 4:32:38 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $314,500 +321.0% | Assets $16,652,082 | EPS -$1.08 | |
| Eyegate Pharmaceuticals Inc (KPRX) | 11/13/2018 4:07:12 PM | View | Financials | Earnings | WIRE | 3Q 2018 | Rev $314,500 +321.0% | Assets $16,652,082 | EPS -$1.08 | Export Earnings Model | |
| EYEGATE PHARMACEUTICALS INC (KPRX) | 8/3/2018 8:49:04 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $242,012 +63.2% | Assets $19,064,791 | EPS -$0.07 | |
| EYEGATE PHARMACEUTICALS INC (KPRX) | 5/29/2018 4:52:43 PM | View | Proxy | SEC | Y 2017 | ||||||
| EYEGATE PHARMACEUTICALS INC (KPRX) | 5/11/2018 8:42:53 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $1,096,008 +493.9% | Assets $11,166,452 | EPS -$0.14 | |
| EYEGATE PHARMACEUTICALS INC (KPRX) | 3/2/2018 4:42:29 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $407,518 -39.1% | Assets $14,305,392 | EPS -$0.93 | |
| EYEGATE PHARMACEUTICALS INC (KPRX) | 11/14/2017 8:45:53 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $74,696 -72.8% | Assets $16,059,413 | EPS -$0.24 | |
| EYEGATE PHARMACEUTICALS INC (KPRX) | 8/4/2017 4:27:01 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $148,290 -36.8% | Assets $18,313,431 | EPS -$0.28 | |
| EYEGATE PHARMACEUTICALS INC (KPRX) | 5/5/2017 4:24:12 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $184,532 | Assets $12,001,311 | EPS -$0.28 | |
| EYEGATE PHARMACEUTICALS INC (KPRX) | 4/28/2017 4:17:52 PM | View | Proxy | SEC | Y 2016 | ||||||
| EYEGATE PHARMACEUTICALS INC (KPRX) | 2/23/2017 4:02:23 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $669,259 | Assets $9,730,602 | ||
| EYEGATE PHARMACEUTICALS INC (KPRX) | 11/1/2016 5:12:26 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $274,289 | Assets $10,616,590 | EPS -$0.36 | |
| EYEGATE PHARMACEUTICALS INC (KPRX) | 8/10/2016 4:46:29 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $234,600 | Assets $12,783,268 | EPS -$0.46 | |
| EYEGATE PHARMACEUTICALS INC (KPRX) | 5/13/2016 5:19:22 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Assets $12,316,872 | EPS -$0.31 | ||
| EYEGATE PHARMACEUTICALS INC (KPRX) | 4/28/2016 4:07:06 PM | View | Proxy | SEC | Y 2015 | ||||||
| EYEGATE PHARMACEUTICALS INC (KPRX) | 3/30/2016 4:08:33 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Assets $9,507,701 | EPS -$2.70 | ||
| EYEGATE PHARMACEUTICALS INC (KPRX) | 11/12/2015 6:09:25 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Assets $10,086,120 | EPS -$0.19 | ||
| EYEGATE PHARMACEUTICALS INC (KPRX) | 8/12/2015 5:16:47 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Assets $1,556,317 | EPS -$0.24 | ||
| EYEGATE PHARMACEUTICALS INC (KPRX) | 5/18/2015 5:12:32 PM | Micro | View | Financials | 10-Q/A | SEC | 1Q 2015 ending: 3/31/2015 | Assets $2,547,064 | EPS -$3.23 |